India has the potential to turn that principle into practice by making the next generation of therapies not only practical but also accessible and affordable. If it succeeds, India won’t just lead the ...

PharmaHopers explains the booming Indian pharma distributorship market, driven by rising demand, tech adoption, and ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...

The deal eliminates tariff barriers and aims to ease regulatory processes, creating room for Indian companies to expand in ...

The India-UK FTA is poised to bolster pharmaceutical and medical device supply chains, enhancing access to affordable ...

Medical device manufacturers anticipate an increase in trade between the two countries but are awaiting clarity on non-tariff ...

Indian pharma a formidable competitor for global manufacturing: Sameer Hiremath: Nandita Vijayasimha, Bengaluru Saturday, July 26, 2025, 08:00 Hrs [IST] Indian pharma presents an ...

The UK and India’s new £4.8bn free trade agreement (FTA) is expected to allow new opportunities for Indian medical device and pharmaceutical manufacturers.

Factors impacting Indian pharmaceutical industry: Dr. R. B. Smarta Thursday, November 30, 2017, 08:00 Hrs [IST] The Indian pharmaceutical industry, which is expected to grow over 15 per cent per annum ...

The deal, which eliminates tariffs on most finished pharmaceutical products and medical devices, is expected to boost India’s ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

YANGON: The Embassy of India in Myanmar, in collaboration with the India-Myanmar Chamber of Commerce and Industry (IMCCI), hosted the "PHARMA CONNECT 2025" event on the evening of July 25 at the Pan ...